Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Peiyukeli
- Development stage
- Unknown
- Lead developer
- Beijing Obstetrics and Gynecology Hospital
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Peiyukeli (also known as Peiyu granules or PYG) is an investigational traditional Chinese medicine (TCM) compound granule preparation composed of 19 different herbs, including Herba Taxilli, Semen Cuscutae, Cortex Eucommiae, Radix Dipsaci, and Rhizoma Dioscoreae. Originally formulated by Professor Zhao Quansong, Peiyukeli is designed to treat patients with threatened abortion of spleen and kidney deficiency syndrome. It is developed as an adjunct to integrated Chinese and Western luteal support in women undergoing in vitro fertilization and embryo transfer (IVF-ET) to improve pregnancy outcomes and reduce early miscarriage rates. Clinical studies, including a large-scale randomized controlled trial conducted by Beijing Obstetrics and Gynecology Hospital, Capital Medical University, have demonstrated that Peiyukeli can significantly reduce early miscarriage rates among women undergoing embryo transfer.
- Other names
- PYGPeiyu GranulePeiyu Granules胚育颗粒
Beyond the preview
Go deeper on Peiyukeli.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Peiyukeli.